Please use this identifier to cite or link to this item: https://doi.org/10.1042/BA20090363
Title: Engineering mammalian cells in bioprocessing - Current achievements and future perspectives
Authors: Lim, Y.
Wong, N.S.C.
Lee, Y.Y.
Ku, S.C.Y.
Wong, D.C.F.
Yap, M.G.S. 
Keywords: Biopharmaceuticals
Biotechnology
Cell engineering
Mammalian cell culture
Metabolic engineering
Recombinant proteins
Issue Date: Apr-2010
Citation: Lim, Y., Wong, N.S.C., Lee, Y.Y., Ku, S.C.Y., Wong, D.C.F., Yap, M.G.S. (2010-04). Engineering mammalian cells in bioprocessing - Current achievements and future perspectives. Biotechnology and Applied Biochemistry 55 (4) : 175-189. ScholarBank@NUS Repository. https://doi.org/10.1042/BA20090363
Abstract: Over the past 20 years, we have seen significant improvements in product titres from 50 mg/l to 5-10 g/l, a more than 100-fold increase. The main methods that have been employed to achieve this increase in product titre have been through the manipulation of culture media and process control strategies, such as the optimization of fed-batch processes. An alternative means to increase productivity has been through the engineering of host cells by altering cellular processes. Recombinant DNA technology has been used to overexpress or suppress specific genes to endow particular phenotypes. Cellular processes that have been altered in host cells include metabolism, cell cycle, protein secretion and apoptosis. Cell engineering has also been employed to improve post-translational modifications such as glycosylation. In this article, an overview of the main cell engineering strategies previously employed and the impact of these strategies are presented. Many of these strategies focus on engineering cell lines with more efficient carbon metabolism towards reducing waste metabolites, achieving a biphasic production system by engineering cell cycle control, increasing protein secretion by targeting specific endoplasmic reticulum stress chaperones, delaying cell death by targeting anti-apoptosis genes, and engineering glycosylation by enhancing recombinant protein sialylation and antibody glycosylation. Future perspectives for host cell engineering, and possible areas of research, are also discussed in this review. © 2010 Portland Press Limited.
Source Title: Biotechnology and Applied Biochemistry
URI: http://scholarbank.nus.edu.sg/handle/10635/90829
ISSN: 08854513
DOI: 10.1042/BA20090363
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

57
checked on Sep 17, 2018

WEB OF SCIENCETM
Citations

68
checked on Sep 17, 2018

Page view(s)

63
checked on Jul 6, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.